Harrow, Inc. (HROW) stock
HROWNasdaqPharmaceutical PreparationsFiscal year ends December 31
$30.12+1.82 (+6.43%)
Close on Nov 13, 2026Market cap $1.13BP/E –Yield –
Harrow total assets
Total assets on the balance sheet at the end of each period.
Harrow's total assets was $443.02M at Sep 30, 2026. For fiscal 2025 it was $399.48M, up 2.7% from the year before. Over ten years it grew 39.7% a year on average. The highest annual figure on record is $399.48M in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $399.48M | +2.7% |
| FY2024 | Dec 31, 2024 | $388.97M | +24.6% |
| FY2023 | Dec 31, 2023 | $312.16M | +98.4% |
| FY2022 | Dec 31, 2022 | $157.38M | +60.1% |
| FY2021 | Dec 31, 2021 | $98.33M | +71.1% |
| FY2020 | Dec 31, 2020 | $57.47M | -2.7% |
| FY2019 | Dec 31, 2019 | $59.09M | +19.5% |
| FY2018 | Dec 31, 2018 | $49.45M | +106.8% |
| FY2017 | Dec 31, 2017 | $23.92M | -12.2% |
| FY2016 | Dec 31, 2016 | $27.25M | +92.8% |
| FY2015 | Dec 31, 2015 | $14.13M | +38.0% |
| FY2014 | Dec 31, 2014 | $10.24M | -35.0% |
| FY2013 | Dec 31, 2013 | $15.76M | +47.2% |
| FY2012 | Dec 31, 2012 | $10.71M | +6551.5% |
| FY2011 | Dec 31, 2011 | $160.96K | -54.3% |
| FY2010 | Dec 31, 2010 | $352.29K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $443.02M | +22.0% |
| Q2 FY2026 | Jun 30, 2026 | $416.82M | +20.8% |
| Q1 FY2026 | Mar 31, 2026 | $419.54M | +15.2% |
| Q4 FY2025 | Dec 31, 2025 | $399.48M | +2.7% |
| Q3 FY2025 | Sep 30, 2025 | $363.07M | +3.3% |
| Q2 FY2025 | Jun 30, 2025 | $345.03M | +12.5% |
| Q1 FY2025 | Mar 31, 2025 | $364.16M | +23.2% |
| Q4 FY2024 | Dec 31, 2024 | $388.97M | +24.6% |
| Q3 FY2024 | Sep 30, 2024 | $351.54M | +22.9% |
| Q2 FY2024 | Jun 30, 2024 | $306.63M | +36.9% |
| Q1 FY2024 | Mar 31, 2024 | $295.54M | +35.9% |
| Q4 FY2023 | Dec 31, 2023 | $312.16M | +98.4% |
| Q3 FY2023 | Sep 30, 2023 | $286.07M | +189.0% |
| Q2 FY2023 | Jun 30, 2023 | $223.99M | +128.4% |
| Q1 FY2023 | Mar 31, 2023 | $217.50M | +122.9% |
| Q4 FY2022 | Dec 31, 2022 | $157.38M | +60.1% |
| Q3 FY2022 | Sep 30, 2022 | $98.99M | -3.7% |
| Q2 FY2022 | Jun 30, 2022 | $98.06M | -8.3% |
| Q1 FY2022 | Mar 31, 2022 | $97.60M | +73.5% |
| Q4 FY2021 | Dec 31, 2021 | $98.33M | +71.1% |
| Q3 FY2021 | Sep 30, 2021 | $102.80M | +72.9% |
| Q2 FY2021 | Jun 30, 2021 | $106.97M | +116.3% |
| Q1 FY2021 | Mar 31, 2021 | $56.25M | +20.0% |
| Q4 FY2020 | Dec 31, 2020 | $57.47M | -2.7% |
| Q3 FY2020 | Sep 30, 2020 | $59.47M | +8.7% |
| Q2 FY2020 | Jun 30, 2020 | $49.45M | -24.1% |
| Q1 FY2020 | Mar 31, 2020 | $46.89M | -29.5% |
| Q4 FY2019 | Dec 31, 2019 | $59.09M | +19.5% |
| Q3 FY2019 | Sep 30, 2019 | $54.70M | +93.4% |
| Q2 FY2019 | Jun 30, 2019 | $65.16M | +147.5% |
| Q1 FY2019 | Mar 31, 2019 | $66.51M | +213.7% |
| Q4 FY2018 | Dec 31, 2018 | $49.45M | +106.8% |
| Q3 FY2018 | Sep 30, 2018 | $28.29M | +7.9% |
| Q2 FY2018 | Jun 30, 2018 | $26.33M | -4.6% |
| Q1 FY2018 | Mar 31, 2018 | $21.20M | -18.1% |
| Q4 FY2017 | Dec 31, 2017 | $23.92M | -12.2% |
| Q3 FY2017 | Sep 30, 2017 | $26.21M | – |
| Q2 FY2017 | Jun 30, 2017 | $27.60M | – |
| Q1 FY2017 | Mar 31, 2017 | $25.88M | – |
| Q4 FY2016 | Dec 31, 2016 | $27.25M | – |
See a number that looks wrong?